Skip to main content

Table 2 Mean, Confidence Interval and Heterogeneity for Secondary Outcome Measures

From: Effect of intermittent fasting on obesity and metabolic indices in patients with metabolic syndrome: a systematic review and meta analysis

Secondary outcome measures

No

publication

Sample size

Mean

95%CI

Heterogeneity text

  

IF

CR

  

I2 (%)

P

Fat mass

5

213

209

−0.46

(−1.16,0.25)

0

0.95

Waist

5

192

190

−0.94

(−2.03,0.15)

21

0.28

Hip circumference

2

109

105

−0.82

(−2.32,0.69)

0

0.95

Glucose

5

217

217

−0.95

(−5.03,3.12)

71

 < 0.01

Insulin

5

217

217

−0.28

(−1.01,0.44)

46

0.12

Systolic blood pressure

4

168

168

1.58

(−0.61,3.77)

0

0.56

Diastolic blood pressure

4

168

168

−0.31

(−1.62,1.01)

35

0.20

Total cholesterol

5

217

217

−1.27

(−6.99,4.44)

0

0.73

Low-density lipoprotein cholesterol

4

196

195

−2.07

(−7.37,3.24)

0

0.92

  1. IF intermittent fasting, CR continuous energy limitation, CI confidence interval, I2 percentage of heterogeneity due to true differences within studies, P p-value for heterogeneity